7851 - 7875 of 9131 Results
Title
Year
-
OPENTitle: Identification of risk factors for impulse-control disorder symptoms in patients with Parkinson’s diseaseJournal Name: Journal of Physics: Conference SeriesPublisher: IOP PublishingVol: 1722Issue #: 1Start Page: 012099End Page: 012099Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1742-6596/1722/1/012099Best OA location URL: https://doi.org/10.1088/1742-6596/1722/1/012099Citation Count: 1
- Fast and robust supervised machine learning approach for classification and prediction of Parkinson’s disease onset2021RESTRICTEDTitle: Fast and robust supervised machine learning approach for classification and prediction of Parkinson’s disease onsetJournal Name: Computer Methods in Biomechanics and Biomedical Engineering: Imaging & VisualizationPublisher: Informa UK LimitedVol: 9Issue #: 6Start Page: 690End Page: 706Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/21681163.2021.1941262Citation Count: 13
- Response to: The need of reliable warning signs for dysphagia in Parkinson’s disease: an often-overlooked issue2020RESTRICTEDTitle: Response to: The need of reliable warning signs for dysphagia in Parkinson’s disease: an often-overlooked issueJournal Name: Expert Review of Gastroenterology & HepatologyPublisher: Informa UK LimitedVol: 15Issue #: 3Start Page: 343End Page: 344Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17474124.2021.1842195Citation Count: 0
- Tablet-based patient educational interventions in care and management of complex movement disorders2021RESTRICTEDTitle: Tablet-based patient educational interventions in care and management of complex movement disordersJournal Name: Disability and Rehabilitation: Assistive TechnologyPublisher: Informa UK LimitedVol: 18Issue #: 5Start Page: 627End Page: 634Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17483107.2021.1900934Citation Count: 3
-
OPENTitle: Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosisJournal Name: Expert Review of ProteomicsPublisher: Informa UK LimitedVol: 18Issue #: 11Start Page: 977End Page: 994Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/14789450.2021.2004890Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/14789450.2021.2004890?needAccess=trueCitation Count: 8
- The Impact of Cloud Management Platforms on Nonprofit Business Models2021RESTRICTEDTitle: The Impact of Cloud Management Platforms on Nonprofit Business ModelsJournal Name: Journal of Technology in Human ServicesPublisher: Informa UK LimitedVol: 39Issue #: 4Start Page: 405End Page: 425Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/15228835.2021.1920556Citation Count: 8
- Parkinson’s Disease Videos on YouTube: Types and Characteristics of Content on Communication and Cognition2021RESTRICTEDTitle: Parkinson’s Disease Videos on YouTube: Types and Characteristics of Content on Communication and CognitionJournal Name: Journal of Consumer Health on the InternetPublisher: Informa UK LimitedVol: 25Issue #: 4Start Page: 335End Page: 349Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/15398285.2021.1980692Citation Count: 2
-
OPENTitle: A technology evaluation of CVT-301 (Inbrija): an inhalable therapy for treatment of Parkinson’s diseaseJournal Name: Expert Opinion on Drug DeliveryPublisher: Informa UK LimitedVol: 18Issue #: 11Start Page: 1559End Page: 1569Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/17425247.2021.1960820Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/17425247.2021.1960820?needAccess=trueCitation Count: 20
- Deep brain stimulation programming strategies: segmented leads, independent current sources, and future technology2021RESTRICTEDTitle: Deep brain stimulation programming strategies: segmented leads, independent current sources, and future technologyJournal Name: Expert Review of Medical DevicesPublisher: Informa UK LimitedVol: 18Issue #: 9Start Page: 875End Page: 891Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17434440.2021.1962286Citation Count: 15
-
OPENTitle: The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemicsJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 6Start Page: 615End Page: 623Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14737175.2021.1923480Best OA location URL: http://hdl.handle.net/11577/3395097Citation Count: 16
-
OPENTitle: Real-world assessment of “OFF” episode–related healthcare resource utilization among patients with Parkinson’s disease in the United StatesJournal Name: Journal of Medical EconomicsPublisher: Informa UK LimitedVol: 24Issue #: 1Start Page: 540End Page: 549Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/13696998.2021.1913009Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.1913009?needAccess=trueCitation Count: 9
-
OPENTitle: An exploration of the coverage of aphasia in the Irish print mediaJournal Name: AphasiologyPublisher: Informa UK LimitedVol: 36Issue #: 3Start Page: 337End Page: 352Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/02687038.2021.1875733Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/02687038.2021.1875733?needAccess=trueCitation Count: 2
-
OPENTitle: Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjectsJournal Name: Current Medical Research and OpinionPublisher: Informa UK LimitedVol: 37Issue #: 10Start Page: 1761End Page: 1768Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/03007995.2021.1965975Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1965975?needAccess=trueCitation Count: 14
-
OPENTitle: Intracellular Thermometry to Study Protein Aggregation Related to Neurodegenerative DiseasesJournal Name: Trends in Biochemical SciencesPublisher: Elsevier BVVol: 46Issue #: 3Start Page: 251End Page: 252Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.tibs.2020.12.003Best OA location URL: http://www.cell.com/article/S096800042030308X/pdfCitation Count: 2
-
OPENTitle: Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imagingJournal Name: Seminars in Arthritis and RheumatismPublisher: Elsevier BVVol: 51Issue #: 5Start Page: 1125End Page: 1133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.semarthrit.2021.08.004Best OA location URL: https://research.vumc.nl/en/publications/d083f460-428b-4cc9-b64c-8e646fc9a1c6Citation Count: 29
- The protean roles of neuroinflammation in trauma, infections, autoimmunity and neurodegeneration2022RESTRICTEDTitle: The protean roles of neuroinflammation in trauma, infections, autoimmunity and neurodegenerationJournal Name: Seminars in ImmunologyPublisher: Elsevier BVVol: 61-64Issue #:Start Page: 101655End Page: 101655Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.smim.2022.101655Citation Count: 3
-
OPENTitle: An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utilityJournal Name: Seizure: European Journal of EpilepsyPublisher: Elsevier BVVol: 101Issue #:Start Page: 156End Page: 161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.seizure.2022.08.003Best OA location URL: http://www.seizure-journal.com/article/S1059131122001820/pdfCitation Count: 11
- Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic Neurons2022RESTRICTEDTitle: Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic NeuronsJournal Name: NeurosciencePublisher: Elsevier BVVol: 506Issue #:Start Page: 114End Page: 126Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2022.10.011Citation Count: 2
- Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach2022RESTRICTEDTitle: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approachJournal Name: NeuropeptidesPublisher: Elsevier BVVol: 96Issue #:Start Page: 102283End Page: 102283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283Citation Count: 11
- Tracer development for PET imaging of proteinopathies2022RESTRICTEDTitle: Tracer development for PET imaging of proteinopathiesJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 114-115Issue #:Start Page: 137End Page: 147Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nucmedbio.2022.04.001Citation Count: 0
- Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease2021RESTRICTEDTitle: Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 186Issue #:Start Page: 108465End Page: 108465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108465Citation Count: 19
- Special Issue on new therapeutic approaches to Parkinson disease2022RESTRICTEDTitle: Special Issue on new therapeutic approaches to Parkinson diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 208Issue #:Start Page: 108998End Page: 108998Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998Citation Count: 5
-
OPENTitle: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse modelJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 218Issue #:Start Page: 109213End Page: 109213Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109213Citation Count: 11
- Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain Stimulation2022OPENTitle: Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain StimulationJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 26Issue #: 2Start Page: 364End Page: 373Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.015Citation Count: 5
- Une valine 11 codée par le gène HLA-DRB1 est associée inversement au risque de maladie de Parkinson et interagit avec l’initiation du tabagisme2022RESTRICTEDTitle: Une valine 11 codée par le gène HLA-DRB1 est associée inversement au risque de maladie de Parkinson et interagit avec l’initiation du tabagismeJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 178Issue #:Start Page: S15End Page: S15Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2022.02.151Citation Count: 0